Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


1.		Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic, Treatment				Completed				18 to 63				Pharmaceutical / Industry				3068A1-400 NCT00418236

Last Modified: 1/8/2009 First Published: 7/1/1999


2.		Phase III Randomized Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				35 and over				NCI				NSABP-P-2 NCT00003906

Last Modified: 5/26/2005 First Published: 8/1/1998


3.		Phase II Study of Raloxifene as a Chemopreventive Agent for Premenopausal Women at High Risk for Developing Invasive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Completed				23 to 47				NCI				NCI-98-C-0123 MB-402, NCT00019500

Last Modified: 10/2/2003 First Published: 2/1/2000


4.		Phase II Randomized Study of Exemestane and Raloxifene in Postmenopausal Women With a History of Stage 0 (Ductal Carcinoma in Situ), I, II, or III Breast Cancer Who Have No Clinical Evidence of Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention, Treatment				Closed				18 and over				NCI				MSKCC-99017 NCI-G99-1662, NCT00004247

Last Modified: 8/1/2000 First Published: 3/1/2000


5.		Phase II Study of Raloxifene in Patients With Recurrent Endometrial Cancer (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NU-98G1 NCI-G00-1710, NCT00004915

Last Modified: 12/1/2002 First Published: 3/1/2002


6.		Randomized Study of Raloxifene With or Without Exercise Versus Exercise Alone in Women Previously Treated for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				Any age				NCI				OHSU-6312 NCI-H02-0086, NCT00031811

Last Modified: 5/8/2007 First Published: 3/1/2002


7.		Pilot Randomized Study of Raloxifene and Goserelin Versus No Medical Intervention in Women at High Genetic Risk for Developing Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Completed				30 to 45				Other				NCRI-IBIS-RAZOR EU-20053, UKCCCR-IBIS-RAZOR, ISRCTN17775670, NCT00031850

Select All on One Page